Skip to main content

Table 1 Characteristics of included studies

From: The effect of rigorous study design in the research of autologous bone marrow-derived mononuclear cell transfer in patients with acute myocardial infarction

Study

BMSC (n)

Control (n)

Cell dose

Injection time

Baseline LVEF (%)

Follow-up

Cao et al.[19]

41

45

5 × 108

7 days

38.8

6 mo

Chang et al. [20]

20

20

1.5 × 109

3 days

52.9

6 mo

Grajeck et al.[21]

31

14

0.41 × 109

4–5 days

55.5

6 mo

Herbots et al.[2]

33

34

3.04 × 108

4–7 days

55.5

4 mo

Huikuri et al.[3]

36

36

4.02 × 108

2.5 days

56.5

6 mo

Meluzin et al.[22]

20

20

1 × 108

5–9 days

40.5

6 mo

Penicka et al.[23]

17

10

26.4 × 108

4–11 days

39

4 mo

Piepoli et al.[24]

19

19

2.48 × 108

4 days

38.7

6 mo

Plewka et al.[25])

40

20

1.44 × 108

7 days

34

6 mo

Schachinger et al.[4]

101

103

2.36 × 108

3–6 days

47.1

4 mo

Suarez de Lezo et al. [26]

10

10

9 × 108

7 days

38

3 mo

Tendera et al.[27]

80

40

1.78 × 108

7 days

37

6 mo

Traverse et al.[5]

30

10

1.5 × 108

4.5 days

38

6 mo

Traverse et al.[6]

58

29

1.5 × 108

14–21 days

47

6 mo

Wohrle et al.[7]

29

13

3.81 × 108

5–7 days

59.6

6 mo

Wollert et al.[28]

30

30

24.6 × 108

4.8 days

50.7

6 mo

Yao et al.[29]

12

12

2.0 × 108

3–7 days

32.4

6 mo

  1. BMSC bone marrow stem cell, LVEF left ventricular ejection fraction.